SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

Harmony Biosciences' Wakix shows promise for significant revenue growth. Find out why HRMY stock’s profitability and pipeline ...

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...

When the company reported VK2735's phase 2 results last year, the stock jumped 121% in one trading session. Viking gave back ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

For 25 years, it was Joe Panetta’s job to tell the story of San Diego’s biotechnology community to the world. And the job ...